These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 39026664)
21. Machine learning identifies ferroptosis-related genes as potential diagnostic biomarkers for osteoarthritis. Qiu Y; Yao J; Li L; Xiao M; Meng J; Huang X; Cai Y; Wen Z; Huang J; Zhu M; Chen S; Long X; Li J Front Endocrinol (Lausanne); 2023; 14():1198763. PubMed ID: 37378023 [TBL] [Abstract][Full Text] [Related]
22. Targeting BCR-ABL-Independent TKI Resistance in Chronic Myeloid Leukemia by mTOR and Autophagy Inhibition. Mitchell R; Hopcroft LEM; Baquero P; Allan EK; Hewit K; James D; Hamilton G; Mukhopadhyay A; O'Prey J; Hair A; Melo JV; Chan E; Ryan KM; Maguer-Satta V; Druker BJ; Clark RE; Mitra S; Herzyk P; Nicolini FE; Salomoni P; Shanks E; Calabretta B; Holyoake TL; Helgason GV J Natl Cancer Inst; 2018 May; 110(5):467-478. PubMed ID: 29165716 [TBL] [Abstract][Full Text] [Related]
23. Identification of Ferroptosis-Related Molecular Clusters and Immune Characterization in Autism Spectrum Disorder. Liu L; Lai Y; Zhan Z; Fu Q; Jiang Y Front Genet; 2022; 13():911119. PubMed ID: 36035135 [No Abstract] [Full Text] [Related]
24. Machine learning identifies ferroptosis-related gene ANXA2 as potential diagnostic biomarkers for NAFLD. Qin J; Cao P; Ding X; Zeng Z; Deng L; Luo L Front Endocrinol (Lausanne); 2023; 14():1303426. PubMed ID: 38192427 [TBL] [Abstract][Full Text] [Related]
25. Identification of ferroptosis-related genes in male mice with sepsis-induced acute lung injury based on transcriptome sequencing. Hu W; Wu Z; Zhang M; Yu S; Zou X BMC Pulm Med; 2023 Apr; 23(1):133. PubMed ID: 37081490 [TBL] [Abstract][Full Text] [Related]
26. Genetic Analysis of Potential Biomarkers and Therapeutic Targets in Ferroptosis from Steroid-Induced Osteonecrosis of the Femoral Head Based on Machine Learning. Zhao J; Guan J; Zhang X; Jiang J; Dou K J Coll Physicians Surg Pak; 2024 Aug; 34(8):916-921. PubMed ID: 39113509 [TBL] [Abstract][Full Text] [Related]
27. Deep sequencing reveals the spectrum of BCR-ABL1 mutations upon front-line therapy resistance in chronic myeloid leukemia: An Eastern-Indian cohort study. Dey S; Basu S; Shah S; Bhattacharyya D; Gupta PP; Acharjee M; Roychoudhury S; Nath S Cancer Treat Res Commun; 2022; 33():100635. PubMed ID: 36155130 [TBL] [Abstract][Full Text] [Related]
28. Presence of novel compound BCR-ABL mutations in late chronic and advanced phase imatinib sensitive CML patients indicates their possible role in CML progression. Akram AM; Iqbal Z; Akhtar T; Khalid AM; Sabar MF; Qazi MH; Aziz Z; Sajid N; Aleem A; Rasool M; Asif M; Aloraibi S; Aljamaan K; Iqbal M Cancer Biol Ther; 2017 Apr; 18(4):214-221. PubMed ID: 28278078 [TBL] [Abstract][Full Text] [Related]
29. Identification of ferroptosis-related subtypes, characteristics of TME infiltration and development of prognostic models in gastric cancer. Tang X; Yu Y; Liu N; Su Y; Zhang K; Zhai Z; Chen C; Sun W; Chen D; Ling R Int Immunopharmacol; 2024 Mar; 130():111610. PubMed ID: 38402832 [TBL] [Abstract][Full Text] [Related]
30. Dasatinib: from treatment of imatinib-resistant or -intolerant patients with chronic myeloid leukemia to treatment of patients with newly diagnosed chronic phase chronic myeloid leukemia. Abbott BL Clin Ther; 2012 Feb; 34(2):272-81. PubMed ID: 22285209 [TBL] [Abstract][Full Text] [Related]
31. LncRNA OIP5-AS1 Promotes the Autophagy-Related Imatinib Resistance in Chronic Myeloid Leukemia Cells by Regulating miR-30e-5p/ATG12 Axis. Dai H; Wang J; Huang Z; Zhang H; Wang X; Li Q; Feng W Technol Cancer Res Treat; 2021; 20():15330338211052150. PubMed ID: 34723728 [No Abstract] [Full Text] [Related]
32. Identifying a novel ferroptosis-related prognostic score for predicting prognosis in chronic lymphocytic leukemia. Pan B; Li Y; Xu Z; Miao Y; Yin H; Kong Y; Zhang X; Liang J; Xia Y; Wang L; Li J; Wu J; Xu W Front Immunol; 2022; 13():962000. PubMed ID: 36275721 [TBL] [Abstract][Full Text] [Related]
33. Clinical significance of BCR-ABL fusion gene subtypes in chronic myelogenous and acute lymphoblastic leukemias. Ye YX; Zhou J; Zhou YH; Zhou Y; Song XB; Wang J; Lin L; Ying BW; Lu XJ Asian Pac J Cancer Prev; 2014; 15(22):9961-6. PubMed ID: 25520136 [TBL] [Abstract][Full Text] [Related]
34. Expression of LYN and PTEN genes in chronic myeloid leukemia and their importance in therapeutic strategy. Ferri C; Bianchini M; Bengió R; Larripa I Blood Cells Mol Dis; 2014; 52(2-3):121-5. PubMed ID: 24091144 [TBL] [Abstract][Full Text] [Related]
35. Andrographolide and its potent derivative exhibit anticancer effects against imatinib-resistant chronic myeloid leukemia cells by downregulating the Bcr-Abl oncoprotein. Liao HC; Chou YJ; Lin CC; Liu SH; Oswita A; Huang YL; Wang YL; Syu JL; Sun CM; Leu CM; Lin CH; Fu SL Biochem Pharmacol; 2019 May; 163():308-320. PubMed ID: 30822403 [TBL] [Abstract][Full Text] [Related]
36. Identification of ferroptosis-related genes in type 2 diabetes mellitus based on machine learning. Wang S; Lu Y; Chi T; Zhang Y; Zhao Y; Guo H; Feng L Immun Inflamm Dis; 2023 Oct; 11(10):e1036. PubMed ID: 37904700 [TBL] [Abstract][Full Text] [Related]
37. Identifification and validation of ferroptosis signatures and immune infifiltration characteristics associated with intervertebral disc degeneration. Zhang F; Cui D; Wang K; Cheng H; Zhai Y; Jiao W; Wang Z; Cui X; Yu H Front Genet; 2023; 14():1133615. PubMed ID: 36911415 [TBL] [Abstract][Full Text] [Related]
38. Targeted chronic myeloid leukemia therapy: seeking a cure. Fausel C J Manag Care Pharm; 2007 Oct; 13(8 Suppl A):8-12. PubMed ID: 17970609 [TBL] [Abstract][Full Text] [Related]
39. Identification of key candidate targets and pathways for the targeted treatment of leukemia stem cells of chronic myelogenous leukemia using bioinformatics analysis. Li H; Liu L; Zhuang J; Liu C; Zhou C; Yang J; Gao C; Liu G; Sun C Mol Genet Genomic Med; 2019 Sep; 7(9):e851. PubMed ID: 31373443 [TBL] [Abstract][Full Text] [Related]
40. ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance. Ferreira AF; Moura LG; Tojal I; Ambrósio L; Pinto-Simões B; Hamerschlak N; Calin GA; Ivan C; Covas DT; Kashima S; Castro FA Blood Cells Mol Dis; 2014; 53(1-2):47-55. PubMed ID: 24629639 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]